Search Results

You searched for : empagliflozin

	CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure. ... May 20
	US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Latest Pharma News Update... Aug 23
	Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ... Jan 07
	Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial ... Nov 19
	Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020... Aug 27
	Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets Alembic receives USFDA approval for their erectile dysfunction drug ... Aug 05
	USFDA gives tentative nod to Zydus for Empagliflozin tablets The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.... Apr 13
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
8 Matching result(s) found!

-Advertisements-

Trending Now
	Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
	FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
	Candy flavoured traps to hook the next generationMay 31, 2024
	Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
	Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
	Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
	Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
	Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
	Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
	FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
	Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
	Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
	The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
	The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
	Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
	AI software could revolutionise voice box cancer treatmentMay 29, 2024
	Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
	Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
	WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
	From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024

Search Results

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

USFDA gives tentative nod to Zydus for Empagliflozin tablets

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Trending Now